Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES

Approved

STANDARD

ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES

Bayer Bulgaria Eood🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 29, 2021
Approval ID: 40626e6da10400cd
Company: Bayer Bulgaria Eood
Type: Standard

Approval Details

Approval Id: 40626e6da10400cd
Drug Cima Aemps Name: ASPIRINA C 400 mg/240 mg COMPRIMIDOS EFERVESCENTES
Register Number: 20000836IP
Holder Company Name: Bayer Bulgaria Eood
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2021-04-29
Dosage Form: COMPRIMIDO EFERVESCENTE
Dose: 400 mg/240 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Bayer Bulgaria Eood

Active Ingredients

ACETILSALICILICO ACIDO

400 mg

ASCORBICO ACIDO

240 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 29, 2021

Approval ID

40626e6da10400cd

Type

Standard

Back to CIMA-AEMPS Approvals